Progression to ARDS in COVID-19: Here’s What It Looks Like

In more severe cases of COVID-19, patients can develop acute respiratory distress syndrome (ARDS), leading to a worse prognosis. This animation illustrates the process of diffuse alveolar damage, thought to be the underlying basis of the development of ARDS in COVID-19 patients.

Advertising Policy

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services Policy

Study Suggests Benefits of Vitamin C for Severe Sepsis

Cleveland Clinic was one of seven enrollment sites across the country chosen for the CITRIS-ALI trial, the first randomized, double-blind, placebo-controlled multicenter trial to assess vitamin C and its potential impact on sepsis and acute respiratory distress syndrome. The findings were recently published in JAMA.

Advertising Policy

Building on the Network Approach to ARDS Research

As one of 12 Clinical Centers in the Prevention and Early Treatment of Acute Lung Injury (PETAL) Network , Cleveland Clinic is helping develop and test novel therapeutic approaches to acute lung injury, aiming for prevention, early diagnosis and improved outcomes.